Tyra Biosciences, Inc. (TYRA)
36.69
-0.44
(-1.18%)
USD |
NASDAQ |
Apr 09, 16:00
36.70
+0.01
(+0.03%)
After-Hours: 20:00
Tyra Biosciences Total Liabilities (Quarterly) : 24.87M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 62.54M |
| Entrada Therapeutics, Inc. | 71.24M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Ionis Pharmaceuticals, Inc. | 3.035B |
| Agios Pharmaceuticals, Inc. | 104.11M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 284.05M |
| Shareholders Equity (Quarterly) | 259.18M |
| Debt to Equity Ratio | 0.0224 |
| Current Ratio | 14.67 |
| Net Debt Paydown Yield | 0.01% |